RedHill Biopharma Ltd. (RDHL) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.2x

Market Cap

$4.41M

MomentumView details →

1D Return

+1.63%

YTD Return

−28.83%

RSI (14)

54.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.2x

Market Cap

$4.41M

RSI (14)

54.6

MomentumView details →

1D Return

+1.63%

YTD Return

−28.83%

SummaryUpdated Dec 1, 2025

RedHill Biopharma Ltd. (NASDAQ:RDHL) is a specialty biopharmaceutical company founded in 2009 and headquartered in Tel Aviv, Israel. The company went public in 2013 and focuses primarily on developing and commercializing treatments for gastrointestinal and infectious diseases. RedHill operates as a clinical-stage biopharmaceutical company with a portfolio of marketed products and an extensive pipeline of investigational drugs in various stages of development.

Ask drillr about RedHill Biopharma Ltd. →

ProfitabilityView details →

Gross Margin

64.45%

Net Margin

−97.52%

EBITDA Margin

−82.78%

ROE (TTM)

211.08%

ROA (TTM)

−50.68%

Asset Turnover

0.52x

GrowthView details →

Revenue YoY

+157.62%

EPS YoY

+90.70%

FCF YoY

+66.12%

Revenue CAGR 3Y

−83.34%

EPS CAGR 3Y

+100.00%

EBITDA YoY

+59.48%

EarningsView details →

EPS (Actual)

−$1.15

EPS Surprise

—

Beats (12Q)

2/12

Next Q EPS Est

−$352.86

Avg Surprise (4Q)

−140.63%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

−0.05x

Current Ratio

0.56x

Quick Ratio

0.42x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

9.55M

Net Income (TTM)

−9.31M

Op. CF (TTM)

−8.20M

Next earningsMar 18, 2027 →

Latest newsMore news →

RedHill acquired global commercialization rights to Ferring's Rebyota and Clenpiq.3d ago

RedHill Biopharma divested its 70% stake in Talicia to Apotex for an $18 million upfront cash payment plus up to $35 million in potential milestone payments.5d ago

Similar companies

Sunshine Biopharma, Inc.SBFM Shuttle Pharmaceuticals Holdings, Inc.SHPH PRF Technologies Ltd.PRFX Sonoma Pharmaceuticals, Inc.SNOA Procaps Group, S.A.PROCW Gelteq Limited Ordinary SharesGELS Find similar companies →

Latest newsMore news →

RedHill acquired global commercialization rights to Ferring's Rebyota and Clenpiq.3d ago RedHill Biopharma divested its 70% stake in Talicia to Apotex for an $18 million upfront cash payment plus up to $35 million in potential milestone payments.5d ago